Bioprinting has become an innovative tool for tissue engineering and regenerative medicine. This technology has been developed to allow construction of biological substitutes mimicking structures and functions of native tissues or organs. 3D Bioprinting enables precise placement of various cell types, biomaterials, and bioactive molecules in a single three-dimensional (3-D) architecture. This session will provide insights into the rapidly developing area of bioprinting and how this technology is being developed for clinical applications as well as the regulatory considerations.
Discuss the fundamentals of Biofabrication.
Discuss the current status of regulatory oversight.
Describe how bioprinting technology is translated into the clinic.
Please note: James Yoo, MD, PhD did not consent to be recorded; therefore, the on-demand presentation and handout have been modified accordingly.